Drug Profile
Telinavir
Alternative Names: SC 52151Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antivirals
- Mechanism of Action Aspartic endopeptidase inhibitors; HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 06 Mar 1995 Discontinued-II for HIV-1 infections in USA (PO)
- 23 Nov 1994 Phase-II clinical trials for HIV-1 infections in USA (Unknown route)